Oral contraceptive administration prevents relapse of periodic psychosis with hyperprolactinemia.
Otsuka
Kotaro
K
Sakai
Akio
A
Okudera
Toshio
T
Shibata
Eri
E
Matoh
Koichi
K
Kawamura
Satoshi
S
D000328:Adult; D018692:Antimanic Agents / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000517:prevention & control* / Q000523:psychology; D008597:Menstrual Cycle / Q000502:physiology / Q000523:psychology; D011618:Psychotic Disorders / Q000150:complications / Q000517:prevention & control* / Q000523:psychology; D055502:Secondary Prevention; D014635:Valproic Acid / Q000627:therapeutic use
D018692:Antimanic Agents; D003278:Contraceptives, Oral, Hormonal; D014635:Valproic Acid